RHONDA MANESSIER: Open Payments
NPI 1083644272 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$463 in 25 payments from 11 companies in 2025. Trend: 2023 $496 · 2024 $519 · 2025 $463
Food & beverage: $463
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $156 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Organon LLC | 3 | $51 |
| Dexcom, Inc. | 2 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Astellas Pharma US Inc | 2 | $32 |
| Abbott Laboratories | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
| Dynavax Technologies Corporation | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: PREVNAR 20, Kerendia, NEXPLANON, NURTEC ODT, Dexcom G6 Transmitter, GEMTESA, Veozah, ELIQUIS.
Industry payments across TX — which companies pay providers there.
